JPH11235521A - Method for producing vinyl alcohol polymer separation membrane by stretching two-stage solidification - Google Patents
Method for producing vinyl alcohol polymer separation membrane by stretching two-stage solidificationInfo
- Publication number
- JPH11235521A JPH11235521A JP4018198A JP4018198A JPH11235521A JP H11235521 A JPH11235521 A JP H11235521A JP 4018198 A JP4018198 A JP 4018198A JP 4018198 A JP4018198 A JP 4018198A JP H11235521 A JPH11235521 A JP H11235521A
- Authority
- JP
- Japan
- Prior art keywords
- coagulation bath
- membrane
- separation membrane
- vinyl alcohol
- coagulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Artificial Filaments (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Abstract
(57)【要約】
【課題】 本発明は新しい膜素材、および新しい装置等
を使用することなく、透水性と透析性を向上させ、バラ
ンスの良いビニルアルコール系共重合体分離膜を得る方
法を提供することである。
【解決手段】 本発明は少なくとも2つの凝固浴を用
い、第一凝固浴出口における膜壁内の溶媒含有率を20
〜80重量%の不完全な状態にしておき、第二凝固浴に
至るまでの間に5〜50%の範囲で延伸した後、緩和さ
せながら第二凝固浴以降の工程で完全に凝固させ分離膜
を製造することを特徴とする分離膜の製造方法である。PROBLEM TO BE SOLVED: To provide a method for obtaining a vinyl alcohol copolymer separation membrane having a good balance by improving water permeability and dialysis without using a new membrane material and a new apparatus. To provide. The present invention uses at least two coagulation baths, and reduces the solvent content in the membrane wall at the outlet of the first coagulation bath to 20%.
8080% by weight in an incomplete state, stretched in the range of 5-50% before reaching the second coagulation bath, then completely coagulated in the process after the second coagulation bath while relaxing, and separated A method for producing a separation membrane, characterized by producing a membrane.
Description
【0001】[0001]
【発明の属する技術分野】本発明はビニルアルコール系
重合体を使用した血液処理用分離膜の製造方法に関す
る。さらに詳しくは透水性と透析性が向上したバランス
の良い血液処理用分離膜、特に人工腎臓用として有用な
分離膜の湿式製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a separation membrane for blood treatment using a vinyl alcohol polymer. More specifically, the present invention relates to a well-balanced separation membrane for blood treatment having improved water permeability and dialysis properties, and more particularly to a wet production method of a separation membrane useful for artificial kidneys.
【0002】[0002]
【従来の技術】分離膜の湿式製造方法は、膜素材のポリ
マーを適当な溶媒に溶解し、この紡糸原液を、例えば中
空糸分離膜の場合は円環状ノズルより凝固溶媒中へ押し
出し、ポリマーを析出凝固させて膜構造を発現させるこ
とを基本としている。従って従来凝固浴はできるだけ完
全に紡糸原液中のポリマーを析出、凝固させることを目
的として組成、濃度、温度、循環量、凝固温度、バスド
ラフトなどの諸条件を検討し、これらの条件設定によっ
て種々の構造、性能を有した分離膜が得られている。例
えば、特開昭55ー110132号、特開昭55ー11
0124号、特開昭55ー35969号等である。ま
た、膜素材のポリマーの溶媒を凝固浴へ添加し、凝固速
度、即ち膜壁中の溶媒の置換速度を調節して優れた血液
透析膜を得ようとする試みは特開昭51ー70698号
などに示されている。さらに特開昭57ー199808
号には、非凝固性の液体中へ紡糸原液を押し出し、冷却
して均質にゲル化させた後、凝固浴に導きそのまま均質
に凝固させる分離膜の湿式法が開示されている。また、
特開昭59ー160507号には少なくとも2つの凝固
浴を用い、第一凝固浴における分離膜膜壁中の溶媒の置
換を中断し、不完全な分離膜を一旦得た後、第二凝固浴
以降の凝固浴で実質的に完全凝固させて分離膜を得る方
法が開示されている。2. Description of the Related Art In a wet production method for a separation membrane, a polymer of a membrane material is dissolved in an appropriate solvent, and this spinning solution is extruded into a coagulation solvent from an annular nozzle in the case of a hollow fiber separation membrane, for example, to polymerize the polymer. It is based on developing a film structure by precipitation and solidification. Therefore, the conventional coagulation bath examines various conditions such as composition, concentration, temperature, circulation amount, coagulation temperature, bath draft, etc. with the aim of precipitating and coagulating the polymer in the spinning solution as completely as possible. A separation membrane having the structure and performance described above is obtained. For example, JP-A-55-110132, JP-A-55-11
No. 0124 and JP-A-55-35969. An attempt to obtain an excellent hemodialysis membrane by adding a solvent of the polymer of the membrane material to a coagulation bath and adjusting the coagulation rate, ie, the rate of replacement of the solvent in the membrane wall, is disclosed in JP-A-51-70698. And so on. Further, Japanese Patent Laid-Open No. 57-199808
In JP-A No. 11-139, there is disclosed a wet method of a separation membrane in which a spinning solution is extruded into a non-coagulable liquid, cooled, uniformly gelled, and then guided to a coagulation bath to uniformly coagulate as it is. Also,
JP-A-59-160507 discloses that at least two coagulation baths are used, the substitution of the solvent in the membrane wall of the separation membrane in the first coagulation bath is interrupted, and an incomplete separation membrane is once obtained. A method of obtaining a separation membrane by substantially completely coagulating in a coagulation bath is disclosed.
【0003】[0003]
【発明が解決しようとする課題】しかし、近年医療の高
度化にともなって血液処理膜に対する要求性能はますま
す高くなっているが、一方使用される血液処理用膜の価
格は低下の一途をたどっている。従って、本発明は新し
い膜素材、および新しい装置等を使用することなく、透
水性と透析性を向上させ、バランスの良いビニルアルコ
ール系重合体分離膜を得る方法を提供することである。However, in recent years, with the advancement of medical treatment, the required performance of blood treatment membranes has been increasing, but the price of blood treatment membranes used has continued to decrease. ing. Accordingly, an object of the present invention is to provide a method for obtaining a vinyl alcohol-based polymer separation membrane with improved balance and improved water permeability and dialysis without using a new membrane material and a new device.
【0004】[0004]
【課題を解決するための手段】本発明者らは、従来より
使用されている装置で、従来より良く知られているビニ
ルアルコール系重合体分離膜の開孔率を上げる方法につ
いて鋭意検討を重ねた結果、第一凝固浴で不完全な凝固
状態の分離膜を作成してから延伸を加え、そして緩和さ
せながら第二凝固浴以降で完全に凝固させると分離膜の
開孔率が向上し、性能が向上することを見いだし本発明
に至った。即ち本発明は少なくとも2つの凝固浴を用い
る湿式紡糸法によるビニルアルコール系重合体分離膜の
製造方法において、第一凝固浴出口における膜壁内の溶
媒含有率を20〜80重量%にして、第二凝固浴までの
間に5〜50%の範囲で延伸した後、ほぼ延伸前の長さ
に緩和させてから第二凝固浴に導くか、または、ほぼ延
伸前の長さの一部まで部分緩和させながら第二凝固に導
き、第二凝固浴以降最終凝固浴までの工程においてほぼ
延伸前の長さまでさらに緩和させるか、あるいは5〜5
0%の範囲で延伸されたまま第二凝固浴に導き、第二凝
固浴以降、最終凝固浴までの工程においてほぼ延伸前の
長さまで緩和させることを特徴とするビニルアルコール
系重合体分離膜の製造方法である。以下に本発明につい
て詳細に説明する。Means for Solving the Problems The present inventors have intensively studied a method of increasing the porosity of a vinyl alcohol polymer separation membrane which has been conventionally well known, using a conventionally used apparatus. As a result, when a separation membrane in an incompletely coagulated state is created in the first coagulation bath, stretching is performed, and when the solidification is completely coagulated after the second coagulation bath while relaxing, the porosity of the separation membrane is improved, The inventors have found that the performance is improved, and have reached the present invention. That is, the present invention provides a method for producing a vinyl alcohol-based polymer separation membrane by a wet spinning method using at least two coagulation baths, wherein the solvent content in the membrane wall at the outlet of the first coagulation bath is 20 to 80% by weight. After stretching in the range of 5 to 50% before the two-coagulation bath, relax to almost the length before stretching and then lead to the second coagulation bath, or partially extend to a part of the length before stretching It is led to the second coagulation while relaxing, and in the process from the second coagulation bath to the final coagulation bath, it is further relaxed to almost the length before stretching, or 5 to 5
A vinyl alcohol-based polymer separation membrane characterized in that it is guided to a second coagulation bath while being stretched in a range of 0%, and is relaxed to a length almost before stretching in a process from the second coagulation bath to a final coagulation bath. It is a manufacturing method. Hereinafter, the present invention will be described in detail.
【0005】[0005]
【発明の実施の形態】なお、ここで言う膜壁内の溶媒含
有率とは第一凝固浴を出た分離膜壁内の全揮発分重量に
対する、溶媒重量の割合のことである。ここで本発明に
おける溶媒とは次の様なものを言う。すなわち全揮発分
中の成分(a)が溶媒と判定される為には、(a)は、
必要なら加熱下に、単独でビニルアルコール系重合体を
15重量%以上溶解する能力を有していなければならな
い。分離膜膜壁内の溶媒含有率の測定は以下の手順で行
う。第一凝固浴出口で分離膜を採取、細断後遠心分離機
により付着液を除去し、湿潤分離膜を得、その重量を秤
量する。次に水で繰り返し抽出し、抽出液中の溶媒量を
ガスクロマトグラフ等により定量する。抽出後の分離膜
は乾燥し、ポリマー重量を測定する。得られた結果より
膜壁中の全揮発分に対する溶媒含有率を計算する。DESCRIPTION OF THE PREFERRED EMBODIMENTS The term "solvent content in the membrane wall" as used herein means the ratio of the solvent weight to the total volatile matter weight in the separation membrane wall leaving the first coagulation bath. Here, the solvent in the present invention means the following. That is, in order for component (a) in all volatile components to be determined as a solvent, (a)
If necessary, it must have the ability to dissolve 15% by weight or more of a vinyl alcohol polymer alone under heating. The measurement of the solvent content in the separation membrane wall is performed in the following procedure. At the outlet of the first coagulation bath, a separation membrane is collected, and after chopping, the adhering liquid is removed by a centrifuge to obtain a wet separation membrane, and its weight is weighed. Next, the mixture is repeatedly extracted with water, and the amount of the solvent in the extract is determined by gas chromatography or the like. After the extraction, the separation membrane is dried, and the weight of the polymer is measured. From the obtained results, the solvent content relative to the total volatile content in the film wall is calculated.
【0006】本発明に使用されるビニルアルコール系重
合体とは、ビニルアルコール単位を30モル%以上、好
ましくは、50モル%以上含む重合体をいい、ビニルエ
ステル類の単独重合体のケン化物や、エチレン、プロピ
レン、アクリロニトリル、塩化ビニル、ビニルピロリド
ン等のビニル単位を含有するビニルアルコール系重合体
(ランダム、ブロック、グラフト共重合体を含む)等を
例示することができる。[0006] The vinyl alcohol polymer used in the present invention refers to a polymer containing 30 mol% or more, preferably 50 mol% or more of a vinyl alcohol unit. And vinyl alcohol-based polymers (including random, block, and graft copolymers) containing vinyl units such as ethylene, propylene, acrylonitrile, vinyl chloride, and vinylpyrrolidone.
【0007】なかでもエチレンービニルアルコール(E
VA)系共重合体は、溶出物が非常に少ないため医療分
野において使用される分離膜の素材として好適である。
特に血液透析、血漿分離等の血液処理に使用される分離
膜の素材としては、通常、重合度800以上、エチレン
含有率10〜60モル%、ケン化度95モル%以上のE
VA系共重合体が使用される。なおかかるEVA系共重
合体としては、例えば、メタクリル酸、ビニルクロライ
ド、メチルメタクリレート、アクリロニトリル等の共重
合可能な重合性単量体が15モル%以下の範囲内で共重
合されていても良い。[0007] Among them, ethylene-vinyl alcohol (E
The VA) -based copolymer is suitable as a material for a separation membrane used in the medical field because of very little eluate.
In particular, as a material for a separation membrane used for blood treatment such as hemodialysis and plasma separation, usually, E having a polymerization degree of 800 or more, an ethylene content of 10 to 60 mol%, and a saponification degree of 95 mol% or more is used.
A VA copolymer is used. In addition, as such an EVA-based copolymer, for example, a copolymerizable monomer such as methacrylic acid, vinyl chloride, methyl methacrylate, and acrylonitrile may be copolymerized within a range of 15 mol% or less.
【0008】次にこれらビニルアルコール系重合体を溶
解する溶媒としては、ジメチルスルホキシド(DMS
O)、N,Nジメチルアセトアミド(DMAc)、ジメ
チルホルムアミド(DMF)、N−メチル−2−ピロリ
ドン(NMP)、N−メチルモルホリン−n−オキシド
(N−MMO)水和物、N−プロパノール類およびそれ
らの含水物等、あるいはこれらを成分とする混合溶媒を
挙げることができるが、本発明の目的とする望ましい透
水性と透析性のバランスの取れた血液処理膜を得るため
には前記重合体に対して特に溶解性が高く製膜条件の制
御がしやすい上、膜内に毒性の強い物質が残る心配のな
いDMSOが最も望ましい。Next, as a solvent for dissolving these vinyl alcohol polymers, dimethyl sulfoxide (DMS) is used.
O), N, N dimethylacetamide (DMAc), dimethylformamide (DMF), N-methyl-2-pyrrolidone (NMP), N-methylmorpholine-n-oxide (N-MMO) hydrate, N-propanols And hydrates thereof and the like, or a mixed solvent containing these as components. In order to obtain a blood treatment membrane having a desirable balance between water permeability and dialysis, which is the object of the present invention, the polymer In particular, DMSO is particularly desirable because it has high solubility and is easy to control the film-forming conditions, and does not have a concern that highly toxic substances remain in the film.
【0009】これら溶媒にビニルアルコール系重合体を
溶解するが、原液中のビニルアルコール系重合体の濃度
は5〜50重量%、好ましくは10〜30重量%であ
る。これより低濃度では製膜後の膜強度が弱くなり、逆
に高濃度では粘度が高くなり製膜しにくくなるので好ま
しくない。なお、原液中にはほう酸、酸化硅素、酸化チ
タン、ポリエチレングリコール、デキストラン等の添加
剤を適宜含んでいても良い。The vinyl alcohol polymer is dissolved in these solvents, and the concentration of the vinyl alcohol polymer in the stock solution is 5 to 50% by weight, preferably 10 to 30% by weight. If the concentration is lower than this, the film strength after film formation becomes weak, and if the concentration is higher, the viscosity becomes high, making film formation difficult, which is not preferable. The stock solution may appropriately contain additives such as boric acid, silicon oxide, titanium oxide, polyethylene glycol, dextran and the like.
【0010】紡糸原液の温度は通常0〜120℃、好ま
しくは40〜90℃が良い。これより高温ではビニルア
ルコール系重合体が分解あるいは変質する恐れがあり、
これより低温では原液粘度が高くなりすぎて製膜が困難
である。[0010] The temperature of the spinning solution is usually 0 to 120 ° C, preferably 40 to 90 ° C. At higher temperatures, the vinyl alcohol polymer may be decomposed or deteriorated,
If the temperature is lower than this, the viscosity of the stock solution becomes too high, and film formation is difficult.
【0011】凝固浴に用いる凝固液としては上記溶媒と
混和性があり、かつビニルアルコール系重合体を凝固さ
せる作用を有するものであれば特に制限はないが、通常
水性の媒体が使用される。かかる凝固液としては例え
ば、DMSO、DMAc、NMP、DMF、アルコール
等の水に可溶性の有機溶媒と水の混合物、あるいは塩化
ナトリウム、塩化カルシウム、硫酸ナトリウム、水酸化
ナトリウム等の無機塩を含有する水溶液などを挙げるこ
とができる。The coagulation liquid used in the coagulation bath is not particularly limited as long as it is miscible with the above-mentioned solvent and has a function of coagulating the vinyl alcohol-based polymer, but an aqueous medium is usually used. Examples of such a coagulating solution include a mixture of water and an organic solvent soluble in water such as DMSO, DMAc, NMP, DMF, and alcohol, or an aqueous solution containing an inorganic salt such as sodium chloride, calcium chloride, sodium sulfate, and sodium hydroxide. And the like.
【0012】上記の製膜原液は、ノズルより凝固浴中に
紡出され、膜として形成される。製膜原液の紡出に当た
っては、所望とする膜の形状によって種々の形状のノズ
ルを使用することができる。例えばスリット状のノズル
を使用すると平膜状に紡出でき、環状ノズルを使用すれ
ば中空糸状、あるいは管状に紡出することができる。な
かでも、占有体積当たりの有効膜面積を大きく取ること
ができる中空糸膜が好ましく、かかる中空糸としては通
常、外径40〜3000μm、膜厚10〜1000μm
程度のものが使用される。The above-mentioned stock solution is spun from a nozzle into a coagulation bath to form a film. In spinning the film forming stock solution, various shapes of nozzles can be used depending on the desired film shape. For example, when a slit-shaped nozzle is used, the fiber can be spun into a flat membrane, and when an annular nozzle is used, the fiber can be spun into a hollow fiber or a tube. Above all, a hollow fiber membrane that can take a large effective membrane area per occupied volume is preferable, and such a hollow fiber usually has an outer diameter of 40 to 3000 μm and a film thickness of 10 to 1000 μm.
Some are used.
【0013】環状ノズルを使用して中空糸を製膜する場
合には、ノズルから紡出された製膜原液の形状を中空糸
に保持する目的で、ノズルの内部に通常、窒素、空気等
の気体、あるいは注入液としてヘキサン等の製膜原液に
対して非凝固性の溶剤が導入される。注入液としては上
記の非凝固性の溶剤のみならず、DMSO、DMAc、
NMP、アルコール等の水に可溶性の有機溶剤と水の混
合物、あるいは塩化ナトリウム、塩化カルシウム、硫酸
ナトリウム、水酸化ナトリウム等の無機塩を含有する水
溶液など製膜原液に対して凝固性を有する液体を使用す
ることもできる。When a hollow fiber is formed into a film using an annular nozzle, nitrogen, air or the like is usually provided inside the nozzle in order to maintain the shape of the stock solution spun from the nozzle into the hollow fiber. A non-coagulable solvent is introduced as a gas or a stock solution such as hexane as an injection liquid. As the injection solution, not only the above non-coagulating solvent but also DMSO, DMAc,
NMP, a mixture of water and an organic solvent soluble in water such as alcohol, or a liquid having a solidifying property with respect to a film forming stock solution such as an aqueous solution containing an inorganic salt such as sodium chloride, calcium chloride, sodium sulfate, and sodium hydroxide. Can also be used.
【0014】上記の凝固液、注入液の凝固性は得られる
膜の表面の構造に影響を与える。凝固液、注入液として
凝固性の良い液体を使用すると膜の表面には緻密層が形
成し易く、また逆に凝固性の低い液体を使用すると膜の
表面には大きな孔径を有する膜を製造することができ
る。このように凝固液、注入液の凝固性を調整すること
で得られる膜の表面構造を制御することができる。The coagulability of the above-mentioned coagulation liquid and injection liquid affects the surface structure of the obtained film. When a liquid with good coagulability is used as a coagulating liquid or an injecting liquid, a dense layer is easily formed on the surface of the film, and when a liquid with low coagulability is used, a film having a large pore diameter is produced on the surface of the film. be able to. Thus, the surface structure of the obtained film can be controlled by adjusting the coagulation properties of the coagulation liquid and the injection liquid.
【0015】第一凝固浴の出口における膜壁内の溶媒含
有率は、20〜80重量%の範囲にする必要がある。よ
り好ましくは30〜50重量%である。溶媒の含有率が
80重量%より大では膜壁内の溶媒置換率が低すぎて第
一凝固浴における膜構造の発現が弱く、この状態で延伸
させても膜構造の変化は起こらず、第二凝固浴以降の条
件により膜構造が決定されてしまい、本発明の目的とす
る優れた分離膜は得られない。The solvent content in the membrane wall at the outlet of the first coagulation bath must be in the range of 20 to 80% by weight. More preferably, it is 30 to 50% by weight. If the content of the solvent is more than 80% by weight, the solvent exchange rate in the membrane wall is too low and the expression of the membrane structure in the first coagulation bath is weak, and even if the film is stretched in this state, the membrane structure does not change. The membrane structure is determined by the conditions after the two-coagulation bath, and an excellent separation membrane aimed at by the present invention cannot be obtained.
【0016】またもし第一凝固浴出口における膜壁内の
溶媒含有率が20%重量より小では膜壁内の溶媒置換率
が進みすぎて第一凝固浴において実質的に膜構造が決定
されてしまうため、この状態で延伸してももはや効果は
発現せず、本発明の目的とする透水性と透析性のバラン
スに優れた膜を得ることができない。If the content of the solvent in the membrane wall at the outlet of the first coagulation bath is smaller than 20% by weight, the solvent exchange rate in the membrane wall is excessively advanced and the membrane structure is substantially determined in the first coagulation bath. Therefore, even if the film is stretched in this state, the effect is no longer exhibited, and a membrane having an excellent balance between water permeability and dialysis, which is the object of the present invention, cannot be obtained.
【0017】膜壁内の溶媒含有率をコントロールする方
法としては、第一凝固浴の溶媒濃度を調整する方法、第
一凝固浴の大きさを変えて滞留時間を調整する方法、第
一凝固浴における膜の移動時間を変えて滞留時間を調整
する方法があるが、溶媒濃度を変える方法、膜の移動時
間を変える方法、または両者を組み合わせる方法でコン
トロールする方が簡単で調整しやすい。Methods for controlling the solvent content in the membrane wall include a method of adjusting the solvent concentration of the first coagulation bath, a method of adjusting the residence time by changing the size of the first coagulation bath, and a method of controlling the residence time. There is a method of adjusting the residence time by changing the membrane moving time in the above, but it is simpler and easier to control by changing the solvent concentration, changing the membrane moving time, or combining them.
【0018】この様に膜壁内の溶媒含有率を20〜80
重量%の間で不完全な凝固状態にして5〜50%の範囲
で延伸させると、延伸による刺激が膜壁内に新たな微孔
の形成を誘発すると推定される。第一凝固浴ですでに形
成されていた微孔は延伸によって一時的に拡大するが、
次の緩和工程で緩和されて元の大きさに戻るので孔径の
揃った微孔が多数形成されるようになり、開孔率が上が
って、性能が向上すると考えられる。As described above, the solvent content in the membrane wall is adjusted to 20 to 80.
When stretched in the range of 5 to 50% with incomplete coagulation between weight%, it is assumed that the stretching stimulus induces the formation of new pores in the membrane wall. The micropores already formed in the first coagulation bath are temporarily expanded by stretching,
It is considered that the pores are relaxed in the next relaxation step and return to the original size, so that a large number of fine pores having a uniform pore diameter are formed, the aperture ratio is increased, and the performance is improved.
【0019】この様にして第一凝固浴で不完全な状態に
凝固された膜は第一凝固浴と第二凝固浴の間で5〜50
%の範囲で延伸される。好ましくは10〜30%であ
る。5%より延伸が小さいと微孔の発達が不充分で充分
な性能が得られない。一方50%より大になると微孔の
大きさが大きくなりすぎ、透水性と透析性のバランスが
悪くなるので好ましくない。The film thus solidified in an incomplete state in the first coagulation bath is 5 to 50 cm between the first coagulation bath and the second coagulation bath.
%. Preferably it is 10 to 30%. If the stretching is less than 5%, the development of micropores is insufficient and sufficient performance cannot be obtained. On the other hand, if it is more than 50%, the size of the micropores becomes too large, and the balance between water permeability and dialysis properties is unfavorably deteriorated.
【0020】さらに本発明で延伸を行う場合は第一凝固
浴と第二凝固浴の間に気相を設けて行う方が効果的であ
り、その気相が第一凝固浴温度より高温であれば、より
効果的である。Further, when stretching is performed in the present invention, it is more effective to provide a gas phase between the first coagulation bath and the second coagulation bath, and if the gas phase is higher than the first coagulation bath temperature. It is more effective.
【0021】一旦延伸された分離膜はほぼ元の長さに緩
和される必要がある。即ち、5〜50%の範囲で延伸さ
れた後、ほぼ延伸前の長さに緩和させてから第二凝固浴
に導くか、または、ほぼ延伸前の長さの一部まで部分緩
和させながら第二凝固に導き、第二凝固浴以降最終凝固
浴までの工程においてほぼ延伸前の長さまでさらに緩和
させるか、あるいは5〜50%の範囲で延伸されたまま
第二凝固浴に導き、第二凝固浴以降、最終凝固浴までの
工程においてほぼ延伸前の長さまで緩和させる必要があ
る。膜の性能を考えると延伸は元の長さに戻す方が好ま
しいが、数%、即ち約5%の範囲で延伸を残したままに
すると中空糸に張りがあり後工程での工程通過性が向上
するので少し延伸を残す方が好ましい。緩和が元の長さ
より過大に長い状態で第二凝固浴における凝固が完結す
ると膜壁内に大きな孔が残ってしまい、透水性と透析性
のバランスが悪くなる。逆に元の長さより短く緩和させ
たくても後の工程通過性が悪くなるので好ましくない。
前述のように膜の緩和は第二凝固浴に入る前に行なって
も良いが、第二凝固浴に入ってから洗浄と同時に行って
もよい。工程簡略化を考えると緩和と洗浄は同時に行う
方が良い。The separation membrane once stretched needs to be relaxed to almost its original length. That is, after the film is stretched in the range of 5 to 50%, the film is relaxed to almost the length before stretching and then guided to the second coagulation bath, or the resin is partially relaxed to a part of the length before stretching, and In the process from the second coagulation bath to the final coagulation bath, it is further relaxed to almost the length before stretching, or it is guided to the second coagulation bath while being stretched in the range of 5 to 50%, and the second coagulation is performed. From the bath to the final coagulation bath, it is necessary to relax the length almost to the length before stretching. Considering the performance of the membrane, it is preferable that the stretching is returned to the original length. However, if the stretching is left in a range of several percent, that is, about 5%, the hollow fiber is stretched and the processability in the subsequent process is reduced. It is preferable to leave a little stretching since it improves. When the coagulation in the second coagulation bath is completed in a state where the relaxation is excessively longer than the original length, large pores remain in the membrane wall, and the balance between water permeability and dialyzability is deteriorated. Conversely, if it is desired to relax the length to be shorter than the original length, it is not preferable because the passability of the subsequent process is deteriorated.
As described above, the relaxation of the film may be performed before entering the second coagulation bath, or may be performed simultaneously with the washing after entering the second coagulation bath. Considering the simplification of the process, it is better to perform the relaxation and the cleaning at the same time.
【0022】また第一凝固浴の温度も膜構造の発現に影
響し、第一凝固浴の温度が紡糸原液のゲル化(白濁化)
温度以下、第二凝固浴以降の温度がゲル化温度以上の時
に本発明の効果は顕著に発現する。ここで言うゲル化温
度とは紡糸原液を1℃毎分の割合で徐々に冷却した際
に、原液が白濁を開始する温度である。第一凝固浴の温
度がゲル化温度より大になると膜の微孔が全体的に大き
くなってしまい透水性と透過性のバランスが悪くなる。
また、第二凝固浴の温度がゲル化温度より小では延伸に
より発生した微孔の発達が悪く、やはり透水性と透過性
のバランスが悪くなる。The temperature of the first coagulation bath also affects the appearance of the membrane structure, and the temperature of the first coagulation bath changes the gelation (cloudiness) of the spinning stock solution.
The effect of the present invention is remarkably exhibited when the temperature is equal to or lower than the temperature and the temperature after the second coagulation bath is equal to or higher than the gelling temperature. The gelation temperature mentioned here is a temperature at which the stock solution starts to become cloudy when the stock solution is gradually cooled at a rate of 1 ° C. per minute. When the temperature of the first coagulation bath is higher than the gelling temperature, the pores of the membrane become large as a whole, and the balance between water permeability and permeability deteriorates.
On the other hand, when the temperature of the second coagulation bath is lower than the gelation temperature, the development of micropores generated by stretching is poor, and the balance between water permeability and permeability is also poor.
【0023】凝固完了後、湿熱処理を行うが本発明にお
いて該湿熱処理温度は、40〜80℃、好ましくは55
〜70℃である。湿熱処理時間が不十分な場合、後工程
における工程通過性が損なわれ、乾燥後の寸法及び性能
の保存安定性が低下する。また湿熱処理が過剰であった
場合、膜構造に変化が生じ本発明の目的とする充分な性
能が得られない。湿熱処理は、通常、水洗を兼ねて温熱
水中に中空糸を通過させるという方法により行われるが
湿熱処理と水洗は必ずしも同時に行われる必要はなく、
飽和水蒸気雰囲気中に中空糸を通過させ、湿熱処理を行
った後、必要な水洗を行うことも可能であるし、逆に水
洗後湿熱処理を行うことも可能である。しかしながら、
連続工程においては工程簡略化という点から、湿熱処理
と水洗は同時に行うのが好ましい。After completion of the solidification, a wet heat treatment is performed. In the present invention, the wet heat treatment temperature is 40 to 80 ° C., preferably 55 to 80 ° C.
7070 ° C. If the time for the wet heat treatment is insufficient, the passability in the subsequent step is impaired, and the storage stability of dimensions and performance after drying is reduced. If the wet heat treatment is excessive, the film structure changes, and the desired performance of the present invention cannot be obtained. The wet heat treatment is usually performed by a method in which the hollow fiber is passed through warm and hot water also for washing, but the wet heat treatment and the water washing need not necessarily be performed simultaneously,
After passing the hollow fiber through a saturated steam atmosphere and performing a wet heat treatment, it is possible to perform necessary water washing, and conversely, it is also possible to perform a wet heat treatment after water washing. However,
In a continuous process, from the viewpoint of simplification of the process, it is preferable to perform the wet heat treatment and the water washing simultaneously.
【0024】湿潤状態の膜は水混和性揮発性有機溶媒に
浸漬し、膜の表面あるいは内部に存在する水を置換後、
常圧ないし減圧にて乾燥させる。この場合の有機溶媒と
しては炭素数1〜5の低級脂肪族アルコールまたはケト
ンが好ましく、例えばメタノール、エタノール、アミル
アルコール、アセトン、メチルエチルケトン、ジエチル
ケトン等が用いられる。なかでもアセトンが特に好まし
い。乾燥は、常圧ないし減圧下で行われるが、その温
度、及び水蒸気圧は、55℃以下、好ましくは50℃以
下で、水蒸気圧は20mmHg以下である。水蒸気圧は
好ましくは10mmHg以下である。このような条件下
で溶媒置換及び乾燥を行うことにより、湿潤時の性能を
維持したまま乾燥を行うことが出来る。The film in a wet state is immersed in a water-miscible volatile organic solvent to replace water present on the surface or inside of the film.
Dry under normal pressure or reduced pressure. As the organic solvent in this case, a lower aliphatic alcohol or ketone having 1 to 5 carbon atoms is preferable, and for example, methanol, ethanol, amyl alcohol, acetone, methyl ethyl ketone, diethyl ketone and the like are used. Of these, acetone is particularly preferred. The drying is performed under normal pressure or reduced pressure, and the temperature and the steam pressure are 55 ° C. or less, preferably 50 ° C. or less, and the steam pressure is 20 mmHg or less. The water vapor pressure is preferably 10 mmHg or less. By performing solvent replacement and drying under such conditions, drying can be performed while maintaining wet performance.
【0025】乾燥された中空糸膜は、主に寸法及び性能
の保存安定性の向上を目的として、乾熱処理を行う。乾
熱処理温度は、40〜70℃、好ましくは55〜65℃
である。これ以上では膜構造に変化が生じ性能が低下す
る。これ以下では充分な熱固定が出来ず、経時的に収縮
が進行し、膜の性能に変化をきたす。乾熱処理雰囲気下
の水蒸気圧は60mmHg以下である必要があり、これ
以上ではビニルアルコール系重合体への水分子の吸着が
起こり、乾熱処理後室温雰囲気下へ放出した際に、この
水分子の脱離にともなって膜構造に変化が生じ性能が低
下する。The dried hollow fiber membrane is subjected to a dry heat treatment mainly for the purpose of improving the storage stability of dimensions and performance. Dry heat treatment temperature is 40-70 ° C, preferably 55-65 ° C
It is. Above this, the film structure changes and the performance decreases. Below this, sufficient heat fixation is not possible, and shrinkage proceeds with time, resulting in a change in the performance of the film. The water vapor pressure in the dry heat treatment atmosphere must be 60 mmHg or less. Above this value, water molecules are adsorbed on the vinyl alcohol polymer, and when released into a room temperature atmosphere after the dry heat treatment, the water molecules are desorbed. The film structure changes with the separation, and the performance is reduced.
【0026】かくして得られた分離膜は乾燥状態におけ
る寸法安定性に優れ、経時変化は起こらないため、保存
に有利である。また、乾燥させているため輸送等にも便
利である。乾燥分離膜は使用前に水または生理食塩水で
再湿潤させることにより乾燥前の性能を再現することが
できる。The separation membrane thus obtained has excellent dimensional stability in a dry state and does not change with time, so that it is advantageous for storage. Moreover, since it is dried, it is convenient for transportation and the like. The dry separation membrane can reproduce the performance before drying by re-wetting with water or physiological saline before use.
【0027】[0027]
【実施例1】エチレン含量33モル%、重合度130
0、ケン化度99.9モル%のエチレンービニルアルコ
ール(EVA)系共重合体をジメチルスルホキシド(D
MSO)に17重量%に溶解し、紡糸原液とした。この
原液のゲル化温度を調べたところ20℃であった。二重
環ノズルを用い、内部注入液として窒素ガスを注入しつ
つ、ノズルドラフト2.0で、0℃、22重量%のDM
SOを含む水溶液からなる第一凝固浴へ原液を押しだ
し、凝固させた。この時第一凝固浴をでた中空糸膜壁内
の溶媒置換率は40重量%であった。第一凝固浴と第二
凝固浴の間隔を2m空送部として設け、25℃雰囲気
下、20%の延伸を行った。延伸した中空糸膜はこのま
ま55℃の第二凝固浴に導びき、水洗しながら元の長さ
に緩和させた。緩和後は従来と同じように水洗、乾燥、
乾熱処理を行い、内径175ミクロン、外径225ミク
ロンの乾燥中空糸膜を得た。表1には中空糸膜を製造す
る紡糸条件を示した。乾燥した中空糸膜の束を有効面積
1.2m2のモジュールに組み立て、ダイアライザー性能
評価基準に従い水系の透水性、尿素クリアランス、及び
アルブミン阻止率を測定した。その結果を表2に示す。Example 1 Ethylene content 33 mol%, degree of polymerization 130
0, an ethylene-vinyl alcohol (EVA) copolymer having a saponification degree of 99.9 mol% was converted to dimethyl sulfoxide (D
MSSO) to obtain a spinning dope. The gelation temperature of this stock solution was 20 ° C. Using a double-ring nozzle, while injecting nitrogen gas as an internal injection liquid, a nozzle draft 2.0 was used at 0 ° C. and 22% by weight of DM.
The undiluted solution was extruded into a first coagulation bath composed of an aqueous solution containing SO, and was coagulated. At this time, the solvent exchange rate in the hollow fiber membrane wall discharged from the first coagulation bath was 40% by weight. The space between the first coagulation bath and the second coagulation bath was provided as a 2 m empty feeding section, and the film was stretched by 20% in a 25 ° C. atmosphere. The stretched hollow fiber membrane was guided to a second coagulation bath at 55 ° C. as it was, and relaxed to the original length while washing with water. After relaxation, wash and dry as before,
Dry heat treatment was performed to obtain a dry hollow fiber membrane having an inner diameter of 175 microns and an outer diameter of 225 microns. Table 1 shows spinning conditions for producing the hollow fiber membrane. The bundle of dried hollow fiber membranes was assembled into a module having an effective area of 1.2 m 2 , and the water permeability, urea clearance, and albumin rejection of the aqueous system were measured according to the dialyzer performance evaluation criteria. Table 2 shows the results.
【0028】実施例2〜実施例7、比較例1〜比較例5 実施例1と同じ紡糸原液を用い、溶媒含有率、延伸率、
第一凝固浴温度、第二凝固浴温度を表1に示すように種
々変える以外は実施例1と同じようにしてEVA系共重
合体膜を製造した。得られたEVA系共重合体膜の性能
を表2に示す。Examples 2 to 7 and Comparative Examples 1 to 5 The same spinning dope as in Example 1 was used.
An EVA copolymer film was produced in the same manner as in Example 1 except that the first coagulation bath temperature and the second coagulation bath temperature were variously changed as shown in Table 1. Table 2 shows the performance of the obtained EVA-based copolymer film.
【0029】実施例8 実施例4で空送部の温度を5℃に設定した以外は全く同
じ条件で紡糸し、中空糸膜を得、膜性能を測定した。そ
の結果を表に示した。実施例4に比べると孔の発現が弱
いため、透析性が若干不充分であったが、透析膜として
は使用できる性能であった。Example 8 Spinning was carried out under exactly the same conditions as in Example 4 except that the temperature of the empty feeding section was set at 5 ° C. to obtain a hollow fiber membrane, and the membrane performance was measured. The results are shown in the table. Since the development of pores was weaker than in Example 4, the dialyzability was slightly insufficient, but the performance was such that it could be used as a dialysis membrane.
【0030】[0030]
【表1】 [Table 1]
【0031】[0031]
【表2】 [Table 2]
【0032】[0032]
【発明の効果】本発明によるビニルアルコール系重合体
分離膜は従来の膜素材、特にEVA系共重合体に従来の
装置を利用して透水性と透析性の向上したバランスのと
れた分離膜を製造できるので、中空糸膜の製造原価を上
げることなく、透水性と透析性を向上させ、バランスの
取れた膜が得られるので人工腎臓用血液透析膜を製造す
る方法としては有益な方法である。The vinyl alcohol polymer separation membrane according to the present invention is obtained by using a conventional membrane material, particularly an EVA copolymer, by using a conventional apparatus to obtain a well-balanced separation membrane having improved water permeability and dialysis. Since it can be manufactured, it is a useful method as a method for manufacturing a hemodialysis membrane for an artificial kidney because a water-permeable and dialysis property is improved without increasing the manufacturing cost of the hollow fiber membrane and a balanced membrane is obtained. .
Claims (3)
糸法によるビニルアルコール系重合体分離膜の製造方法
において、第一凝固浴出口における膜壁内の溶媒含有率
を20〜80重量%にして、第二凝固浴に至るまでの間
に5〜50%の範囲で延伸した後、ほぼ延伸前の長さに
緩和させてから第二凝固浴に導くか、または、ほぼ延伸
前の長さの一部まで部分緩和させながら第二凝固に導
き、第二凝固浴以降最終凝固浴までの工程においてほぼ
延伸前の長さまでさらに緩和させるか、あるいは5〜5
0%の範囲で延伸されたまま第二凝固浴に導き、第二凝
固浴以降、最終凝固浴までの工程においてほぼ延伸前の
長さまで緩和させることを特徴とするビニルアルコール
系重合体分離膜の製造方法。1. A method for producing a vinyl alcohol-based polymer separation membrane by a wet spinning method using at least two coagulation baths, wherein the solvent content in the membrane wall at the outlet of the first coagulation bath is 20 to 80% by weight. After stretching in the range of 5 to 50% before reaching the second coagulation bath, the film is relaxed to almost the length before stretching, and then guided to the second coagulation bath, or the length before stretching is almost equal to one. To the second coagulation while partially relaxing up to the portion, and in the steps from the second coagulation bath to the final coagulation bath, it is further relaxed to a length almost before stretching, or 5 to 5
A vinyl alcohol-based polymer separation membrane characterized in that it is guided to a second coagulation bath while being stretched in a range of 0%, and is relaxed to a length almost before stretching in a process from the second coagulation bath to a final coagulation bath. Production method.
度以下、第二凝固浴の温度がゲル化温度以上である請求
項1記載のビニルアルコール系重合体分離膜の製造方
法。2. The method for producing a vinyl alcohol-based polymer separation membrane according to claim 1, wherein the temperature of the first coagulation bath is equal to or lower than the gelling temperature of the spinning dope and the temperature of the second coagulation bath is equal to or higher than the gelation temperature.
糸法によるビニルアルコール系重合体分離膜が血液処理
用透析膜である請求項1記載のビニルアルコール系重合
体分離膜の製造方法。3. The method for producing a vinyl alcohol polymer separation membrane according to claim 1, wherein the vinyl alcohol polymer separation membrane by a wet spinning method using at least two coagulation baths is a dialysis membrane for blood treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4018198A JPH11235521A (en) | 1998-02-23 | 1998-02-23 | Method for producing vinyl alcohol polymer separation membrane by stretching two-stage solidification |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4018198A JPH11235521A (en) | 1998-02-23 | 1998-02-23 | Method for producing vinyl alcohol polymer separation membrane by stretching two-stage solidification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11235521A true JPH11235521A (en) | 1999-08-31 |
Family
ID=12573621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4018198A Pending JPH11235521A (en) | 1998-02-23 | 1998-02-23 | Method for producing vinyl alcohol polymer separation membrane by stretching two-stage solidification |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11235521A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010143647A1 (en) * | 2009-06-09 | 2010-12-16 | 国立大学法人山口大学 | Hollow fiber membrane and manufacturing method therefor |
-
1998
- 1998-02-23 JP JP4018198A patent/JPH11235521A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010143647A1 (en) * | 2009-06-09 | 2010-12-16 | 国立大学法人山口大学 | Hollow fiber membrane and manufacturing method therefor |
| JP5637483B2 (en) * | 2009-06-09 | 2014-12-10 | 国立大学法人山口大学 | Hollow fiber membrane and method for producing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS61257203A (en) | Hydrophilic porous membrane and its preparation | |
| JPH06165926A (en) | Polysulfone-based hollow fiber membrane and method for producing the same | |
| EP0066408B1 (en) | Porous membrane | |
| US5290448A (en) | Polyacrylonitrile membrane | |
| EP1134019B1 (en) | Hollow fiber membrane and process for producing the same | |
| GB2086798A (en) | Microporous cellulose membrane | |
| JP4605937B2 (en) | Polyketone porous material | |
| JP2003010654A (en) | Manufacturing method of hollow fiber membrane | |
| JPH11235521A (en) | Method for producing vinyl alcohol polymer separation membrane by stretching two-stage solidification | |
| JPH03254826A (en) | Preparation of polysulfone semipermeable membrane | |
| JP4659166B2 (en) | Film-forming stock solution and method for producing ethylene-vinyl alcohol polymer film | |
| JP4722297B2 (en) | Ethylene-vinyl alcohol polymer hollow fiber membrane | |
| JP4672128B2 (en) | Hollow fiber membrane and method for producing the same | |
| JP2000237558A (en) | High performance permselective hollow fiber membrane | |
| JPH09225274A (en) | Membrane forming solution and method for producing ethylene-vinyl alcohol copolymer membrane | |
| JP2000354745A (en) | Ethylene-vinyl alcohol-based separation membrane and method for producing the same | |
| JP2001038169A (en) | Plasma component separation membrane | |
| JP3203047B2 (en) | Method for producing ethylene vinyl alcohol copolymer hollow fiber membrane | |
| JP2001038154A (en) | Separation membrane for plasma components | |
| JP3032618B2 (en) | Hollow fiber membrane for hemodialysis and method for producing the same | |
| JP4794716B2 (en) | Hollow fiber membrane and method for producing the same | |
| JPH0938473A (en) | Method for producing polysulfone-based porous hollow fiber membrane | |
| JP4381022B2 (en) | Hollow fiber blood purification membrane | |
| JPH0271828A (en) | Production of hollow yarn membrane of ethylene-vinyl alcohol copolymer | |
| JPS63156836A (en) | Molded porous aromatic polyamide article and production thereof |